19.12.2012 Views

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Drug Name<br />

Pediatric Dose<br />

Ipratropium bromide (Atrovent) -- A muscarinic antagonist with potent<br />

bronchodilating effects. May improve pulmonary mechanics significantly<br />

in infants with BPD. Inhaled ipratropium bromide is poorly absorbed<br />

systemically.<br />

0.025-0.08 mg/kg inhaled via nebulization q6h (dilute in 1.5-2 mL <strong>of</strong><br />

0.9% NaCl)<br />

Contraindications Documented hypersensitivity<br />

Interactions<br />

Drugs with anticholinergic properties, such as dronabinol, may increase<br />

toxicity; albuterol increases effects <strong>of</strong> ipratropium<br />

Pregnancy C - Safety for use during pregnancy has not been established.<br />

Precautions<br />

Not indicated for acute episodes <strong>of</strong> bronchospasm; caution in narrowangle<br />

glaucoma, prostatic hypertrophy, and bladder neck obstruction<br />

Drug Category: Corticosteroids -- Produced by the adrenal gland. Mineralocorticoids are produced<br />

in the adrenal medulla and primarily affect fluid and electrolyte balance. Glucocorticoids possess<br />

strong anti-inflammatory properties and affect the metabolism <strong>of</strong> many tissues.<br />

Dexamethasone (Decadron) -- Has many pharmacologic benefits but<br />

significant adverse effects. It stabilizes cell and lysosomal membranes,<br />

increases surfactant synthesis, increases serum vitamin A<br />

concentration, inhibits prostaglandin and leukotriene, decreases PE,<br />

breaks down granulocyte aggregates, and improves pulmonary<br />

Drug Name microcirculation. Adverse effects are hyperglycemia, hypertension,<br />

weight loss, GI bleeding or perforation synthesis, cerebral palsy, adrenal<br />

suppression, and death.<br />

Routine use <strong>of</strong> dexamethasone in infants with BPD is not currently<br />

recommended unless severe pulmonary disease exists.<br />

Loading dose: 0.2-0.5 mg/kg PO/IV<br />

Pediatric Dose<br />

Maintenance dose: 0.1 mg/kg PO/IV q6-8h<br />

Contraindications Documented hypersensitivity; active bacterial or fungal infection<br />

Effects decrease with coadministration <strong>of</strong> barbiturates, phenytoin, and<br />

Interactions rifampin; dexamethasone decreases effect <strong>of</strong> salicylates and vaccines<br />

used for immunization<br />

Pregnancy C - Safety for use during pregnancy has not been established.<br />

Not routinely recommended for BPD secondary to possible detrimental<br />

long-term effects on neurologic outcome; increases risk <strong>of</strong> multiple<br />

complications, including severe infections; monitor adrenal insufficiency<br />

when tapering drug; abrupt discontinuation <strong>of</strong> glucocorticoids may cause<br />

Precautions<br />

adrenal crisis; hyperglycemia, edema, osteoporosis, osteonecrosis,<br />

myopathy, peptic ulcer disease, hypokalemia, euphoria, psychosis,<br />

myasthenia gravis, growth suppression, and infections are possible<br />

complications <strong>of</strong> glucocorticoid use

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!